US-headquartered clinical research organisation (CRO) INC Research has promoted Garth Tierney to executive vice president, Asia/Pacific.
Based at the firm’s South Australia site, Tierney will be responsible for driving strategic development and overall growth in the region.
He joined the company in 2011 as regional general manager, Australia and Southeast Asia, following INC Research’s acquisition of Trident Clinical Research, an Australia-based CRO co-founded by Tierney.
“INC Research is experiencing tremendous opportunity to help drug developers navigate the diverse and complex landscape of conducting trials across the Asia/Pacific region, especially as many countries are poised to significantly increase their investment in clinical research,” said Tierney.
“This is an exciting time within this developing region and I look forward to helping our customers leverage the benefits of Asia/Pacific to advance their clinical development programmes.”
Prior to founding Trident, he held several senior management and operational management positions within the clinical research sector, in both CRO and pharmaceutical companies.
He takes over from Kelvin Logan, who retires from the post in April.
“Asia/Pacific is a key focus area for INC Research because our customers are demanding a strong partner for on-the-ground expertise to help design and execute custom research programmes,” said COO Alistair Macdonald.
“Garth is the obvious choice to take over the helm in the region based on his extensive knowledge and operational prowess.
“Additionally, I’d like to personally thank Kelvin for all of his tremendous accomplishments in building the company’s Asia/Pacific operations into what they are today.”